The results of SRSF3 were reported systemically in human pan-cancer first by us and it may indicate that SRSF3 may act as an oncogenic driver and an interesting biomarker for tumor monitoring in further research (29, 30). The gene discussed is SRSF3; the disease is neoplasm.